Mechanical Thrombectomy Devices Market Report 2025

The mechanical thrombectomy devices market size has grown strongly in recent years. It will grow from $1.39 billion in 2024 to $1.52 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth during the historic period can be attributed to rising stroke incidence, an expanding aging population, increasing demand for minimally invasive procedures, higher hospital admissions for acute ischemic stroke, and the early approvals of thrombectomy devices.

The mechanical thrombectomy devices market size is expected to see strong growth in the next few years. It will grow to $2.16 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period is expected to be driven by increasing adoption of mechanical thrombectomy in emerging markets, rising reimbursement for stroke interventions, higher prevalence of cardiovascular diseases, expansion of ambulatory surgical centers, and a growing number of stroke cases linked to lifestyle factors. Key trends during this period include the integration of artificial intelligence for stroke detection, development of robotic-assisted thrombectomy systems, advancements in catheter navigation technologies, miniaturization of thrombectomy devices, and the use of 3D printing for device prototyping.

The rising prevalence of stroke is expected to drive growth in the mechanical thrombectomy devices market in the coming years. Stroke occurs when blood flow to a part of the brain is interrupted or reduced, leading to brain cell death from a lack of oxygen and nutrients. The increasing incidence of stroke is largely due to aging populations, as older individuals face higher risks because of natural changes in blood vessels and overall health. Mechanical thrombectomy devices play a critical role in stroke treatment by rapidly removing blood clots from blocked brain arteries, restoring blood flow, minimizing brain damage, and significantly improving patient recovery outcomes. For example, in October 2023, the World Economic Forum, a Switzerland-based non-profit organization, reported that stroke deaths could rise by 50% by 2050. This trend underscores how the growing prevalence of stroke is fueling demand for mechanical thrombectomy devices.

Companies in the mechanical thrombectomy devices market are advancing technology to improve the efficiency and safety of procedures. Innovations such as dual clot detection algorithms are being developed to enhance clot removal while ensuring patient safety. These algorithms use both pressure and flow data to accurately identify and distinguish blood clots from normal blood flow during thrombectomy. For instance, in January 2023, Penumbra Inc., a US-based healthcare company, launched the Lightning Flash system, an advanced mechanical thrombectomy device designed to revolutionize clot removal. Combining powerful aspiration technology with a precision-engineered catheter, it efficiently and safely removes large blood clots, including venous thrombi and pulmonary emboli, enabling faster procedures while minimizing complications and improving patient outcomes.

In April 2022, Wallaby Medical LLC, a China-based medical device company, acquired Phenox GmbH for \$579.95 million. This acquisition allows Wallaby Medical to integrate complementary neurovascular technologies and expand its global presence, aiming to become a leading provider of innovative stroke treatment solutions. Phenox GmbH, based in Germany, specializes in manufacturing mechanical thrombectomy devices.

Major players in the mechanical thrombectomy devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Becton Dickinson and Company, Koninklijke Philips N.V., Stryker Corporation, Shandong Weigao Group Medical Polymer Co. Ltd., Boston Scientific Corporation, Terumo Corporation, Teleflex Incorporated, Merit Medical Systems Inc., Inari Medical Inc., AngioDynamics Inc., LeMaitre Vascular Inc., Imperative Care Inc., Wallaby Medical Inc., Acandis GmbH & Co. KG, Inquis Medical Inc., NeuroVasc Technologies Inc., and Route 92 Medical Inc.

North America was the largest region in the mechanical thrombectomy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in mechanical thrombectomy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the mechanical thrombectomy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

Mechanical thrombectomy devices are medical instruments designed to physically remove blockages from blood vessels using minimally invasive techniques. They are engineered to navigate precisely through the vascular system, allowing for the safe capture and extraction of obstructions while minimizing damage to surrounding tissues. These devices feature controlled operation, effective grasping mechanisms, and reliable retrieval capabilities, helping to restore normal blood flow within the affected vessel.

The primary types of mechanical thrombectomy devices include stent retrievers, catheter-based thrombectomy devices, mechanical aspiration devices, and combination devices. Stent retrievers are specifically used to remove blood clots from blocked cerebral arteries during stroke treatment by temporarily trapping and extracting the clot. These devices utilize various technologies, including manual mechanical thrombectomy devices, automated devices, electromechanical systems, and hybrid models. They are applied in treating ischemic stroke, peripheral artery disease (PAD), coronary thrombosis, and post-surgical thrombosis, and are distributed through direct sales, distributors and wholesalers, online platforms, and retail pharmacies. Key end users include hospitals, ambulatory surgical centers, specialized invasive care centers, and research and academic institutions.

The mechanical thrombectomy devices market research report is one of a series of new reports that provides mechanical thrombectomy devices market statistics, including the mechanical thrombectomy devices industry global market size, regional shares, competitors with the mechanical thrombectomy devices market share, detailed mechanical thrombectomy devices market segments, market trends, and opportunities, and any further data you may need to thrive in the mechanical thrombectomy devices industry. This mechanical thrombectomy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The mechanical thrombectomy devices market consists of sales of guidewires, microcatheters, balloon catheters, aspiration pumps, embolic protection devices, angioplasty balloons, contrast media, and hemostatic devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.